Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 2Completed 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Shock, Septic 1Myofibroma 1Leiomyoma 1Diabetes Insipidus 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × Vasopressins × Clear all
NCT04874246 2023-06-26

VALENTINE

Seoul National University Hospital

Phase NA Completed
39 enrolled

Diabetes Insipidus, Leiomyoma, Myofibroma

NCT01718613 2018-05-18

VANCS II

Instituto do Cancer do Estado de São Paulo

Phase 3 Completed
250 enrolled

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡